Amgen Astellas Biopharma Gearing Up for 2020 Takeoff as Stand-Alone Subsidiary

June 20, 2017
Steve Sugino, President & Representative Director, Amgen Astellas BioPharma Amgen Astellas Biopharma (AABP), a Japanese joint venture of the two namesake companies, is making steady headway towards its envisaged takeoff as a wholly owned subsidiary of US biotech giant Amgen...read more